A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John S Salmon, MD
Atrium Health Levine Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Levine Cancer Institute-Albemarle
Albemarle, North Carolina, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Levine Cancer Institute - Ballantyne
Charlotte, North Carolina, United States
- Levine Cancer Institute - Mallard Creek
Charlotte, North Carolina, United States
- Levine Cancer Institute - Pineville
Charlotte, North Carolina, United States
- Levine Cancer Institute - Southpark
Charlotte, North Carolina, United States
- Levine Cancer Institute - University
Charlotte, North Carolina, United States
- Levine Cancer Institute-South Tryon
Charlotte, North Carolina, United States
- Levine Cancer Institute - Concord
Concord, North Carolina, United States
- Levine Cancer Institute-Monroe
Monroe, North Carolina, United States
- Levine Cancer Institute - Cleveland
Shelby, North Carolina, United States
- Low Country Hematology Oncology
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jun 2014
- Primary completion
- 28 Jun 2017
- Completion
- 28 Jun 2017
- Last update posted
- 21 Apr 2022
- Registered enrollment
- 20
- Registry id
- NCT02080260
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.